| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8439308 | European Journal of Cancer | 2018 | 10 Pages |
Abstract
Iterative curative-intent treatment can be performed in up to 40% of patients with relapse after CRS and HIPEC for CRPM, and is associated with prolonged survival in selected patients.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Maximiliano Gelli, Janina F.L. Huguenin, Thierry de Baere, Léonor Benhaim, Antoine Mariani, Valerie Boige, David Malka, Isabelle Sourouille, Michel Ducreux, Dominique Elias, Diane Goéré,